Biological staging of incipient, in situ, and invasive breast carcinomas

Annals of the New York Academy of Sciences

Volumn 784, Issue , 1996, Pages 381-394

  Querzoli, Patrizia ^a   Albonico, Giuseppe ^a   Ferretti, Stefano ^a   Rinaldi, Rosa ^a   Nenci, Italo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; BREAST CARCINOMA; CANCER STAGING; CARCINOMA IN SITU; CELL NUCLEUS; CELL PROLIFERATION; CHROMOSOME 11; CHROMOSOME 6; CONFERENCE PAPER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PHENOTYPE; SEGMENTAL MASTECTOMY; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0029883332     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb16252.x     Document Type: Conference Paper

References (36)

1. RUSSO, R., B. GUSTERSON, A. E. ROGERS, I. H. RUSSO, R. S. WELLINGS & M. J. VAN ZWEITEN. 1990. Biology of disease: comparative study of human and rat mammary tumorigenesis. Lab. Invest. 62(3): 244-278.
2. RUSSO, I. H. & J. RUSSO. 1995. Mammary carcinogenesis: role of differentiation in tumor initiation. Surg. Pathol. 5(4): 307-327.
3. GASPARINI, G., F. POZZA & A. L. HARRIS. 1993. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J. Natl. Cancer Inst. 85: 1206-1209.
4. LEONG, S. Y. A. & W. A. RAYMOND. 1989. Prognostic parameters in breast cancer. Pathology 21: 169-175.
5. CLARK, G. M., C. R. WENGER, S. BEARDSLEE, M. A. OWENS, G. POUNDS, T. OLDAKER et al. 1993. How to integrate steroid hormone receptor, flow cytometric, and other prognostic information with regard to primary breast cancer. Cancer 71: 2157-2162.
6. ELLEDGE, R. M., W. L. MCGUIRE & C. K. OSBORNE. 1992. Prognostic factors in breast cancer. Semin. Oncol. 19: 244-253.
7. MCGUIRE, W. L., A. K. TANDON, D. C. ALLRED, G. C. CHAMNESS & G. M. CLARK. 1990. How to use prognostic factor in axillary node-negative breast cancer patients. J. Natl. Cancer Inst. 82: 1006-1015.
8. SILVESTRINI, R., E. BENINI, M. G. DAIDONE, S. VENERONI, P. BORACCHI, V. CAPPELLETTI et al. 1993. p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J. Natl. Cancer Inst. 85: 965-970.
9. WELLS, W. A., R. RAINER & U. MEMOLI. 1993. Equipment, standardization, and application of image processing. Am. J. Clin. Pathol. 99: 48-56.
10. BACUS, J. W. & L. J. GRACE. 1987. Optical microscope system for standardized cell measurement and analyses. Appl. Opt. 26: 3280-3293.
11. BACUS, S., J. L. FLOWERS, M. F. PRESS, J. W. BACUS & K. S. MCCARTY. 1988. The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am. J. Clin. Pathol. 90: 233-239.
12. BACUS, S. S., S. G. RUBY, D. S. WEINBERG, D. CHIN, R. ORTIZ & J. W. BACUS. 1990. Her-2/neu oncogene expression and proliferation in breast cancers. Am. J. Pathol. 137: 103-111.
13. BACUS, S. S., D. M. CHIN, R. K. STERN, R. ORTIZ, S. G. RUBY & D. S. WEINBERG. 1992. Her-2/neu oncogene expression, DNA ploidy, and proliferation index in breast cancer. Anal. Quant. Cytol. Histol. 14: 433-445.
14. BACUS, S. S., R. GOLDSCHMIDT, D. CHIN, G. MORAN, D. WEINBERG & J. W. BACUS. 1989. Biological grading of breast cancer using antibodies to proliferating cells and other markers. Am. J. Pathol. 135: 783-792.
15. ALDENDERFER, M. S. & R. K. BLASHFIELD. 1984. Cluster Analysis. Sage University Paper Series in Quantitative Applications in the Social Sciences (1984 Series No. 07-044). Sage Pub. Beverly Hills/London.
16. LEE, E. & M. DESU. 1972. A computer program for comparing k samples with right censored data. Comput. Programs Biomed. 2: 315-321.
17. ZAFRANI, B., A. LEROYER, A. FOURQUET, M. LAURENT, D. TROPHILME, P. VALIDIRE & X. SASTRE-GARAU. 1994. Mammographically detected ductal in situ carcinoma of the breast analyzed with a new classification: a study of 127 cases - correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. Semin. Diagn. Pathol. 11(3): 208-214.
18. VAN DE VIJVER, M. J. 1993. Molecular genetic changes in human breast cancer. In Advances in Cancer Research. Volume 61. G. F. Van de Woude & G. Klein, Eds.: 25-55. Academic Press. New York/London.
19. KINSEL, L. B., E. SZABO, G. L. GREEN, J. KONRATH, G. S. LEIGHT & K. S. MCCARTY. 1989. Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Res. 49: 1052-1056.
20. QUERZOLI, P., S. FERRETTI, A. MARZOLA, D. TASSINARI, M. INDELLI, E. MARCHETTI et al. 1992. Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer. Tumori 78: 287-290.
21. PRESS, M., M. C. PIKE, R. V. CHAZIN, G. HUNG, J. A. UDOVE, M. MARKOWICZ et al. 1993. Her-2/neu expression in node-negative breast cancer: direct tissue quantification by computerized image analysis and association of overexprssion with increased risk of recurrent disease. Cancer Res. 53: 4960-4970.
22. PERTSCHUK, L. P., D. S. KIM, K. NAYER, J. G. FELDMAN, K. B. EISEMBERG et al. 1990. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Cancer 66: 1663-1670.
23. MCREADY, H. W., J. W. CHAPMAN, B. G. MOBBS & M. E. TRUDEAU. 1993. The predictive value of ERICA in breast cancer recurrence: a univariate and multivariate analysis. Mod. Pathol. 6: 748-754.
24. LOCKER, A. P., K. BIRRELL, J. A. BELL, R. I. NICHOLSON, C. W. ELSTON et al. 1992. Ki-67 immunoreactivity in breast carcinoma: relationship to prognostic variables and short-term survival. Eur. J. Surg. Oncol. 18: 224-229.
25. TOIKKANEN, S., H. HELIN, J. ISOLA & H. JOENSUU. 1992. Prognostic significance of Her-2 oncoprotein expression in breast cancer: a 30-year follow-up. J. Clin. Oncol. 10: 1044-1048.
26. VERONESE, S. M., M. GAMBACORTA, O. GOTTARDI, F. SCANZI, M. FERRARI & P. LAMPERTICO. 1993. Proliferation index as a prognostic marker in breast cancer. Cancer 71: 3926-3931.
27. PINDER, S. E., P. WENCYK, D. M. SIBBERING, J. A. BELL, C. W. ELSTON & R. NICHOLSON. 1995. Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: association with other prognostic factors and survival. Br. J. Cancer 71: 146-149.
28. ESTEBAN, J. M., A. CHUL, H. BATTIFORA & B. FELDER. 1994. Predictive value of estrogen receptors evaluated by quantitative immunohistochemical analysis in breast cancer. Am. J. Clin. Pathol. 102: 9-12.
29. WINTZER, H. O., I. IRMGARD ZIPFEL, B. SCHULTE-MONTING, U. HELLERICH & S. VON KLEIST. 1991. Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer 67: 421-428.
30. SLUYSER, M. 1990. Steroid/thyroid receptor-like proteins with oncogenic potential: a review. Cancer Res. 50: 451-458.
31. LAW, M. L., F. T. KAO & Q. WEI. 1987. The progesterone receptor gene maps to human chromosome 11q13, the site of the mammary oncogene int-2. Proc. Natl. Acad. Sci. U.S.A. 84: 2877-2881.
32. BUR, M. E., M. J. ZIMAROWSKY, S. J. SCHNITT, S. BAKER & R. LEW. 1992. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer 69: 1174-1181.
33. WILBUR, D. C. & G. H. BARROWS. 1993. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study. Mod. Pathol. 6: 114-120.
34. ALLRED, D. C., M. A. BUSTAMANTE, C. O. DANIEL, H. V. GASKILL & A. B. CRUZ. 1990. Immunohistochemical analysis of estrogen receptor in human breast carcinomas. Arch. Surg. 125: 107-113.
35. HELIN, H. J., M. J. HELLE, O. KALLIONIEMI & J. J. ISOLA. 1989. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Cancer 63: 1761-1767.
36. LIU, E., A. THOR & M. HE. 1992. The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene 7: 1027-1032.